We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LULU icon
151
lululemon athletica
LULU
$13.4B
$25.6M 0.13%
143,898
+38,575
+37% +$7.73M
CM icon
152
Canadian Imperial Bank of Commerce
CM
$108B
$25.5M 0.13%
319,456
-7,133
-2% -$537K
PWR icon
153
Quanta Services
PWR
$93.1B
$25.4M 0.13%
61,361
+5,003
+9% +$1.94M
CBRE icon
154
CBRE Group
CBRE
$42.1B
$25M 0.13%
158,680
-1,974
-1% -$305K
PAYC icon
155
Paycom
PAYC
$7.05B
$25M 0.13%
120,029
+21,006
+21% +$4.73M
APP icon
156
Applovin
APP
$139B
$24.7M 0.13%
34,325
+2,593
+8% +$1.2M
OC icon
157
Owens Corning
OC
$11.6B
$24.6M 0.13%
174,164
-4,241
-2% -$622K
C icon
158
Citigroup
C
$223B
$23.6M 0.12%
232,098
+7,496
+3% +$711K
BMO icon
159
Bank of Montreal
BMO
$125B
$23.5M 0.12%
180,563
+173,758
+2,553% +$20.6M
KLAC icon
160
KLA
KLAC
$266B
$23.3M 0.12%
216,480
+2,720
+1% +$254K
MTLS
161
Materialise
MTLS
$373M
$23.2M 0.12%
10,000
PDD icon
162
Pinduoduo
PDD
$121B
$23.1M 0.12%
175,000
+107,200
+158% +$12.7M
TGT icon
163
Target
TGT
$63.7B
$23.1M 0.12%
257,793
+2,828
+1% +$278K
MDGL icon
164
Madrigal Pharmaceuticals
MDGL
$12.7B
$22.9M 0.12%
49,965
RARE icon
165
Ultragenyx Pharmaceutical
RARE
$2.65B
$22.7M 0.12%
754,714
+228,447
+43% +$6.85M
RYTM icon
166
Rhythm Pharmaceuticals
RYTM
$7.28B
$22.4M 0.12%
221,863
-90,589
-29% -$8.41M
BIIB icon
167
Biogen
BIIB
$29.5B
$22.2M 0.12%
158,821
-4,494
-3% -$607K
CI icon
168
Cigna
CI
$77B
$22.2M 0.12%
77,163
+2,214
+3% +$655K
MFC icon
169
Manulife Financial
MFC
$73.2B
$22.2M 0.12%
711,534
+85,354
+14% +$2.63M
KMX icon
170
CarMax
KMX
$8.29B
$22.2M 0.12%
494,079
+469,573
+1,916% +$28M
CME icon
171
CME Group
CME
$91.8B
$22M 0.12%
81,594
-50,987
-38% -$13.9M
CBOE icon
172
Cboe Global Markets
CBOE
$30.2B
$22M 0.12%
89,839
+42,984
+92% +$10.3M
TOST icon
173
Toast
TOST
$17.9B
$22M 0.12%
602,200
+59,045
+11% +$2.56M
DLR icon
174
Digital Realty Trust
DLR
$72.4B
$21.9M 0.11%
126,837
+100,505
+382% +$17.2M
MLYS icon
175
Mineralys Therapeutics
MLYS
$2.4B
$21.5M 0.11%
567,781
-256,406
-31% -$5.55M

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.